Literature DB >> 12783844

Typical type 2 diabetes mellitus and HFE gene mutations: a population-based case - control study.

David J Halsall1, Ian McFarlane, Jian'an Luan, Timothy M Cox, Nicholas J Wareham.   

Abstract

Diabetes mellitus is a recognized consequence of hereditary haemochromatosis. Whether the common HFE mutations, that associate with this condition and pre-dispose to increases in serum iron indices, are over-represented in diabetic populations remains controversial. We present data from the largest case-control study of the C282Y and H63D HFE allele frequencies in typical type 2 diabetes mellitus, as defined by an age of onset greater than 30 years and no requirement for insulin in the first year post-diagnosis. We also present a meta-analysis of all similar studies to date. We see no evidence for over-representation of iron loading HFE alleles in type 2 diabetes mellitus, suggesting that screening for HFE mutations in this population is of no value.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783844     DOI: 10.1093/hmg/ddg149

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

Review 1.  Diabetes and hemochromatosis.

Authors:  T Creighton Mitchell; Donald A McClain
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 2.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice.

Authors:  Kristina M Utzschneider; Kris V Kowdley
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

3.  Association of insulin resistance with serum ferritin and aminotransferases-iron hypothesis.

Authors:  Jean Huang; Rudruidee Karnchanasorn; Horng-Yih Ou; Wei Feng; Lee-Ming Chuang; Ken C Chiu; Raynald Samoa
Journal:  World J Exp Med       Date:  2015-11-20

4.  High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis.

Authors:  D A McClain; D Abraham; J Rogers; R Brady; P Gault; R Ajioka; J P Kushner
Journal:  Diabetologia       Date:  2006-03-15       Impact factor: 10.122

5.  The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2.

Authors:  Rafael Oliva; Anna Novials; Mayka Sánchez; Marga Villa; Mercedes Ingelmo; Mónica Recasens; Carlos Ascaso; Miquel Bruguera; Ramón Gomis
Journal:  Endocrine       Date:  2004-07       Impact factor: 3.633

6.  Mendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studies.

Authors:  Roman Pfister; Stephen Sharp; Robert Luben; Paul Welsh; Inês Barroso; Veikko Salomaa; Aline Meirhaeghe; Kay-Tee Khaw; Naveed Sattar; Claudia Langenberg; Nicholas J Wareham
Journal:  PLoS Med       Date:  2011-10-25       Impact factor: 11.069

7.  Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study.

Authors:  Gavin Willis; Vicky Bardsley; Ian W Fellows; Ray Lonsdale; Jennie Z Wimperis; Barbara A Jennings
Journal:  BMC Gastroenterol       Date:  2005-06-01       Impact factor: 3.067

8.  Investigating GSTT1 and GSTM1 null genotype as the risk factor of diabetes type 2 retinopathy.

Authors:  Alamdar Dadbinpour; Mohammad Hasan Sheikhha; Mojtaba Darbouy; Mohammad Afkhami-Ardekani
Journal:  J Diabetes Metab Disord       Date:  2013-12-19

9.  Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action.

Authors:  Inês Barroso; Jian'an Luan; Rita P S Middelberg; Anne-Helen Harding; Paul W Franks; Rupert W Jakes; D Clayton; Alan J Schafer; Stephen O'Rahilly; Nicholas J Wareham
Journal:  PLoS Biol       Date:  2003-10-13       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.